Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance

Homeostatic model assessment N-terminal telopeptide Osteopontin Bone remodeling
DOI: 10.1210/jc.2007-2383 Publication Date: 2008-03-12T03:33:44Z
ABSTRACT
Osteopontin (OPN) is a multifunctional protein involved in bone metabolism, cardiovascular disease, diabetes, and obesity. OPN levels are elevated the plasma adipose tissue of obese subjects, decreased with diet-induced weight loss.We investigated effect bariatric surgery on concentrations morbidly patients.The study was performed at university hospital.We 40 patients aged 43.1 +/- 1.8 yr, scheduled to undergo surgery. Roux-en-Y gastric bypass (RYGB) 30 subjects (27 females, three males), laparoscopic adjustable banding (LAGB) 10 (eight two males).All were studied before 1 yr (10.3-14.8 months) after intervention.OPN, leptin, C-reactive protein, insulin, homeostatic model assessment insulin resistance index, calcium, 25-hydroxyvitamin D, C telopeptide, osteocalcin determined.Both procedures significantly reduced body weight, mass Plasma increased from 31.4 3.8 52.8 3.7 ng/ml RYGB (P < 0.001) 29.8 6.9 46.4 10.6 LAGB = 0.042). Preoperative correlated age, postoperative OPN. Postoperative telopeptide osteocalcin.One year LAGB, biomarkers turnover. Unlike other proinflammatory cytokines, does not normalize but increases further
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (54)